Holdings
Tema Oncology ETF
As of May 31, 2026, Tema Oncology ETF reported 53 positions worth US$168M. Largest: Revolution Medicines, Inc., Eli Lilly And Company and Roche Holding Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 86,450 | US$13.6M | −12,131 | May 31, 2026 |
| Eli Lilly And Company | 7,684 | US$8.49M | +1,119 | May 31, 2026 |
| Roche Holding Ltd | 17,288 | US$7.42M | +3,717 | May 31, 2026 |
| Cogent Biosciences, Inc. | 206K | US$7.22M | +71,061 | May 31, 2026 |
| Novartis Ag | 47,020 | US$7.1M | +336 | May 31, 2026 |
| Immunome, Inc. | 316K | US$6.89M | +120K | May 31, 2026 |
| Celcuity Inc. | 47,450 | US$6.31M | +12,079 | May 31, 2026 |
| Merck & Company, Inc. | 52,978 | US$6.29M | +3,348 | May 31, 2026 |
| Astrazeneca Plc | 33,501 | US$6.23M | −1,819 | May 31, 2026 |
| Nuvalent, Inc. | 53,763 | US$5.93M | +4,524 | May 31, 2026 |